Directors of the Board and Executive Team (As of November 1, 2025)
|
Representative Director of the Board, Chief Executive Officer |
Akihisa Harada |
|
President, Representative Director of the Board, Chief Operating Officer |
Akihiro Tsujimura |
|
Chairman, Director of the Board |
Costa Saroukos |
|
Director of the Board |
Ryousuke Tanabe |
|
Director of the Board |
Yuji Sugimoto |
|
Director of the Board |
Masashi Suekane |
|
Director of the Board |
Hiroki Inada |
|
Director of the Board |
William Cozean |
|
Director of the Board |
Nicholas Gattas |
|
Corporate Auditor |
Satomi Takada |
|
Corporate Auditor |
Shintaro Kohmoto |
|
Chief Transformation Officer & General Counsel, Head of Business Development Div. |
Kazumasa Nagayama |
|
Chief Business Officer |
Sean Ryan |
|
Chief Financial Officer, Head of Finance Div. |
Amit Singh |
|
Chief Human Resources Officer |
Naoki Ohta |
|
Chief Information Officer, Head of IT Digital Div. |
Keitaro Shigemasa |
|
Chief Medical Officer, Head of Global R&D, and Global Development & Medical Affairs Div. |
Bijan Nejadnik |
|
Executive Officer, Head of Corporate Strategy Div. |
Tetsurou Iwata |
|
Executive Officer, Head of Legal, Compliance, and Intellectual Property Div. |
Michihisa Yatou |
|
Executive Officer, Head of Human Resources & General Affairs Div. |
Tomoaki Tokuno |
|
Executive Officer, Head of Research Div. |
Naoya Masutomi |
|
Executive Officer, Head of Development & Medical Affairs Div. |
Yousuke Kimura |
|
Executive Officer, Head of Product Supply Div. |
Kenji Taguchi |
|
Executive Officer, Head of Quality & Vigilance Div. |
Masanobu Kono |
|
Executive Officer, Head of Japan Pharmaceutical Business Div. |
Yasutaka Kuragaki |
|
Executive Officer, Head of North America Business Div. |
Yasutoshi Kawakami |
|
Executive Officer, Head of Asia and Europe Business Div. |
Toshifumi Tada |
|
Executive Officer, Head of Market Access and Government Affairs |
Simon Collier |